MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Nectar Lifesciences
Nectar Lifesciences
BSE: 532649|NSE: NECLIFE|ISIN: INE023H01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 17, 17:00
17.96
-2.11 (-10.51%)
VOLUME 141,212
LIVE
NSE
May 17, 17:00
17.90
-2.15 (-10.72%)
VOLUME 353,655
Management Interviews on Nectar Lifesciences
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
See 2% margin growth in FY14: Nectar Lifesciences 

1.54 pm | 16 May 2013 |  Source: CNBC-TV18

In an upbeat mood post the numbers, Aryan Goyal of Nectar Lifesciences is confident that the company would see robust numbers going ahead. ...

1
Quick Links for Nectar Lifesciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.